F Yavuz Selected Research

1-nitroso-5,6-dihydrothymine

1/2020

Monocyte/HDL ratio predicts hypertensive complications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F Yavuz Research Topics

Disease

1	Atrial Fibrillation 01/2021
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2020
1	Heart Failure 01/2018
1	Atherosclerosis 04/2017
1	Hypertension (High Blood Pressure) 04/2016
1	Rheumatoid Arthritis 04/2016
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2016
1	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2016
1	Gingival Overgrowth 04/2016
1	Diarrhea 04/2016
1	Fatigue 09/2014
1	Myasthenia Gravis 09/2014
1	Osteoporosis 09/2014
1	Muscle Weakness 09/2014
1	Hyperplasia 06/2014

Drug/Important Bio-Agent (IBA)

1	1-nitroso-5,6-dihydrothymineIBA 01/2020
1	Procollagen Type IIBA 01/2018
1	CollagenIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 04/2017
1	HDL LipoproteinsIBA 04/2017
1	Pharmaceutical PreparationsIBA 04/2016
1	Leflunomide (Arava)FDA LinkGeneric 04/2016
1	Cholecalciferol (Vitamin D3)FDA Link 09/2014
1	TabletsIBA 09/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2014
1	deflazacortIBA 09/2014
1	Ibandronic Acid (Boniva)FDA Link 09/2014
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 09/2014
1	CalciumIBA 09/2014

Therapy/Procedure

2	Therapeutics 01/2021 - 09/2014
1	Percutaneous Coronary Intervention 01/2021
1	Defibrillators (Defibrillator) 01/2021
1	Stents 06/2014